Search Results
Jun 07, 2026, 20:00 ET Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
key investigational candidates including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 x 4-1BB bispecific antibody), ATG-125 (B7-H3 × PD-L1 bispecific ADC), ATG-207 (αCD3-TGF-β bifunctional fusion protein), as well as T cell engager (TCE) programs developed using Antengene's proprietary
More news about: Antengene Corporation Limited
Jun 07, 2026, 17:30 ET Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
-0.80 % b-8.4 % b
More news about: NOVO NORDISK INC.
Jun 07, 2026, 17:30 ET Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
how we can enhance outcomes by combining them with amylin analogs—ultimately helping patients achieve the blood glucose results they need," said Akshay B. Jain, MD, FRCPC, senior author of the study. "The combination of cagrilintide and semaglutide worked better than either of those components on their
More news about: American Diabetes Association
Jun 07, 2026, 16:45 ET Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
Olezarsen in Reducing TriglyceridesResearchers conducted two phase 3 randomized controlled trials, CORE-TIMI 72a (617 patients) and CORE2-TIMI 72b (446 patients), to evaluate the effectiveness of olezarsen, a targeted medication designed to lower dangerously high triglyceride levels in people whose
More news about: American Diabetes Association
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
had no history of heart attack or stroke, an LDL-C ≥ 90 mg/dL, or non-high-density lipoprotein cholesterol (non-HDL-C) ≥ 120 mg/dL, or apolipoprotein B ≥ 80 mg/dL; and treated with highest tolerated dose of statin and/or ezetimibe. The median baseline LDL-C was 122 mg/dL (IQR, 104-149 mg/dL) on local
More news about: Amgen
Jun 07, 2026, 14:30 ET 頭對頭：埃諾格魯肽體重降幅顯著優於司美格魯肽35%
參考文獻：1 2026 ADA poster 12-B. Study number SCW0502-11222 Ji L, et al. Lancet Diabetes Endocrinol. 2025 Sep;13(9):777-7893 Mullard A. Nat Rev
More news about: 杭州先為達生物科技股份有限公司
Jun 07, 2026, 14:30 ET Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
website: www.sciwind.com.cn References2026 ADA poster 12-B. Study number SCW0502-1122Ji L, et al. Lancet Diabetes Endocrinol. 2025 Sep;13(9):777-789Mullard A. Nat Rev Drug Discov. 2023 May;22(5)347-348.
More news about: Sciwind Biosciences Co., Ltd.
Jun 07, 2026, 08:00 ET Unlocking the Americas: Air Canada and Abra Group Sign Memorandum to Expand Travel and Connectivity between Canada, Latin America and Beyond
second-oldest airline in the world, operates a fleet primarily comprised of A320 and B787 passenger aircraft, as well as cargo aircraft. GOL, one of Brazil's leading airlines, operates a fleet largely composed of B737 passenger aircraft. Wamos Air is a leading European provider of wide-body Aircraft,
More news about: Abra Group
Jun 06, 2026, 21:52 ET A New Era Begins: Cal Poly Unveils the John Madden Football Center
with a John Madden Day celebration at Mustang Memorial Field. Kickoff is at 7 p.m. The game will air on ESPN.NOTE: Photos and b-roll clips of today's ceremony are
More news about: Cal Poly in San Luis Obispo
Jun 06, 2026, 20:27 ET 전 세계 출산 지연 및 난임 증가로 국경 간 난임 치료 수요 확대
multimedia:https://www.prnewswire.com/kr/news-releases/uC804u002DuC138uACC4u002DuCD9CuC0B0u002DuC9C0uC5F0u002DuBC0Fu002DuB09CuC784u002DuC99DuAC00uB85Cu002DuAD6DuACBDu002DuAC04u002DuB09CuC784u002D-302793336.htmlSOURCE
More news about: TFC Taipei Fertility Center
Jun 06, 2026, 11:37 ET XTransfer et Société Générale s'associent pour simplifier les paiements internationaux pour les transactions commerciales mondiales
XTransfer, a déclaré : « Nous sommes heureux de signer ce protocole d'accord avec Société Générale pour renforcer X-Net, un réseau de règlement international B2B unifié au niveau mondial et une plateforme de gestion des risques développée par XTransfer, avec une connectivité bancaire plus approfondie pour les
More news about: XTransfer
Jun 06, 2026, 09:07 ET コンピューテックス2026（Computex 2026）：AMZFAST、ゲーミングモニターの枠を超え、スマートディスプレイ、有機EL技術、400Hzのeスポーツ向け性能を展開
Gamingスイートが搭載されています。ラインナップには、ワンクリックで4K/160HzモードとFHD/320Hzモードを切り替えられ、映像への没入感と競技向け性能のどちらを重視するかに応じて柔軟に選択できるAMZG27D1UL DUAL Modeも含まれます。ゲーミング向け以外にも、AMZFASTはクリエイター向けおよび生産性向上用途のディスプレイを複数展示しました。AMZG34C85Lは、DCI-P3カバー率98%の34インチ5K2Kウルトラワイド仕様を採用しており、B27A2Uは、4K解像度、120HzのIPSパネル、DCI-P3色精度99%、90W USB-C充電を組み合わせ、プロフェッショナル用途のワークフローに対応します。フラッグシップモデルのAMZG49C7は、1台のシームレスなディスプレイで、QHDモニター2台分に相当する49インチ5K
More news about: AMZFAST
Jun 06, 2026, 09:00 ET Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
dosing options.Data Highlights the Promise of Monthly Injection as an Effective Obesity Treatment for Weight LossVESPER-3 is a 2b trial evaluating whether berobenatide can successfully transition from once-weekly to once-monthly dosing while still maintaining weight loss and tolerability.
More news about: American Diabetes Association
Jun 06, 2026, 09:00 ET New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
https://pubmed.ncbi.nlm.nih.gov/41381175/7 Hepprich, M., Roser, P., Stiebitz, S., Felix, B., Schultes, B., Schmitz, D., Rutishauser, J., Schubert, S., Aberle, J., & Rudofsky, G. (2023). Awareness and knowledge of diabetic ketoacidosis in people
More news about: Abbott
Jun 06, 2026, 06:46 ET '시진핑 영도하의 중국의 거버넌스' 제1권 러시아어판, 상트페테르부르크에서 출간
multimedia:https://www.prnewswire.com/kr/news-releases/u0027uC2DCuC9C4uD551u002DuC601uB3C4uD558uC758u002DuC911uAD6DuC758u002DuAC70uBC84uB10CuC2A4u0027u002DuC81Cu0031uAD8Cu002DuB7ECuC2DCuC544uC5B4-302793227.htmlSOURCE
More news about: Xinhua
Jun 06, 2026, 06:36 ET Xinhua Silk Road: 산둥성 웨이하이 찾는 한국 관광객 사이에서 파크골프 관광 인기
multimedia:https://www.prnewswire.com/kr/news-releases/u0078u0069u006Eu0068u0075u0061u002Du0073u0069u006Cu006Bu002Du0072u006Fu0061u0064u003Au002DuC0B0uB465uC131u002DuC6E8uC774uD558uC774u002DuCC3E-302793226.htmlSOURCE
More news about: Xinhua Silk Road
Jun 05, 2026, 20:30 ET 46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000
Elana B. Araj: Litigation (New York)
More news about: Greenberg Traurig, LLP
Jun 05, 2026, 19:30 ET Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
Prediction: One Size Does Not Fit AllSunday, June 7 from 12:30-1:30 p.m. CTErnest N. Morial Convention Center, ePoster Theater B (Halls B1-C)About American Diabetes Association's 2026 Scientific Sessions The ADA's 2026 Scientific Sessions, the world's largest
More news about: American Diabetes Association
Jun 05, 2026, 19:30 ET Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026
most common adverse events were gastrointestinal, and the majority were mild to moderate in severity. The safety and tolerability profile in this phase 2b trial was consistent with other incretin and amylin-based therapies. These results support further investigation of zenagamtide in phase 3 trials.1Based
More news about: NOVO NORDISK INC.
Jun 05, 2026, 17:01 ET Food Safety Testing Market Expected to Reach $44.1 Billion by 2033, at a CAGR of 7% : Allied Market Research
https://www.alliedmarketresearch.com/checkout-final/63f8fee53b6b6e916559861689c43bb3Segment AnalysisBy Type: Pathogen Leads, GMO and Chemical Testing
More news about: Allied Market Research
Jun 05, 2026, 16:30 ET Mynd.ai Receives NYSE American Non-Compliance Notice
equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years; and (b) Section 1003(a)(ii) of the Company Guide, which requires a company to have stockholders' equity of $4.0 million or more if it has reported losses from
More news about: Mynd.ai
Jun 05, 2026, 14:45 ET Legendary Fruit Company Enters Letter of Intent with Gebbers Farms
Legendary Fruit Company ("Legendary") today announced that it has entered into a letter of intent with Brewster Heights Packing & Orchards ("BHPO"), d/b/a as Gebbers Farms ("Gebbers"), under which Legendary will acquire substantially all of its assets through a court-supervised sale process. Upon
More news about: Legendary Fruit Company
Jun 05, 2026, 13:08 ET William Pitt Sotheby's International Realty and Julia B. Fee Sotheby's International Realty Associates Recognized Among the Nation's Best
York:Bedford: Amy & JoannaIrvington: HCH Team at Julia B. Fee Sotheby's International RealtyLarchmont: Carey and Cary Team at Julia B. Fee Sotheby's International Realty, The Rosenblum TeamRye: Amy Ensign & Whitney OkunTop
More news about: William Pitt and Julia B. Fee Sotheby's International Realty
Jun 05, 2026, 12:50 ET GreenCore Solutions Corp. (GSC) Signs Multi-Year Asia BPC Supply Deal as Inbound Agent Traffic Hits Record Levels -- Asia-Pacific Crosses 1 Million Inbound Agent Requests
stack. Per customer agreement, GSC does not disclose further customer detail. The timing tracks the importance of the Asia-Pacific region in B2B agentic procurement. It is the world's largest beauty, personal care, and hygiene market, valued at USD $150–170 billion and roughly 40% of global revenue
More news about: Greencore Solutions Corp.
Jun 05, 2026, 12:30 ET Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference
recently enrolled its first patient in the Phase 2b CARDINAL clinical trial, which aims to demonstrate treatment of rhinovirus infections with vapendavir may improve upper and lower airway symptoms, reduce
More news about: Altesa Biosciences Inc.